Stockreport

Aviragen Adjourns Special Meeting of Stockholders Until February 9, 2018

Atea Pharmaceuticals, Inc. - common stock  (AVIR) 
PDF ATLANTA, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Aviragen Therapeutics, Inc. (NASDAQ:AVIR) today announced that its Special Meeting of Stockholders, scheduled for and conven [Read more]